DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Holdings Increased by American Century Companies Inc.

American Century Companies Inc. increased its stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 7.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,482,953 shares of the medical instruments supplier’s stock after acquiring an additional 179,119 shares during the period. American Century Companies Inc. owned approximately 1.22% of DENTSPLY SIRONA worth $61,850,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Texas Permanent School Fund Corp boosted its stake in shares of DENTSPLY SIRONA by 262.1% during the 2nd quarter. Texas Permanent School Fund Corp now owns 158,572 shares of the medical instruments supplier’s stock valued at $3,950,000 after buying an additional 114,779 shares during the period. United Services Automobile Association bought a new position in shares of DENTSPLY SIRONA in the 2nd quarter valued at approximately $379,000. Connable Office Inc. acquired a new stake in DENTSPLY SIRONA in the 2nd quarter worth approximately $324,000. New Mexico Educational Retirement Board boosted its position in DENTSPLY SIRONA by 306.6% during the second quarter. New Mexico Educational Retirement Board now owns 43,500 shares of the medical instruments supplier’s stock worth $1,084,000 after purchasing an additional 32,801 shares during the period. Finally, Truepoint Inc. acquired a new position in DENTSPLY SIRONA during the second quarter valued at approximately $2,740,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Price Performance

Shares of NASDAQ:XRAY opened at $26.28 on Monday. The business’s 50 day moving average is $25.40 and its 200-day moving average is $28.09. The company has a current ratio of 1.33, a quick ratio of 0.87 and a debt-to-equity ratio of 0.57. The firm has a market capitalization of $5.33 billion, a PE ratio of -59.73, a PEG ratio of 1.22 and a beta of 1.00. DENTSPLY SIRONA Inc. has a 1-year low of $23.58 and a 1-year high of $37.60.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its quarterly earnings results on Wednesday, July 31st. The medical instruments supplier reported $0.49 earnings per share for the quarter, missing analysts’ consensus estimates of $0.50 by ($0.01). DENTSPLY SIRONA had a positive return on equity of 11.86% and a negative net margin of 4.75%. The business had revenue of $984.00 million for the quarter, compared to analyst estimates of $993.61 million. During the same quarter in the prior year, the firm earned $0.51 EPS. The firm’s quarterly revenue was down 4.3% on a year-over-year basis. Sell-side analysts predict that DENTSPLY SIRONA Inc. will post 1.99 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Shareholders of record on Friday, September 27th will be paid a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 2.44%. The ex-dividend date of this dividend is Friday, September 27th. DENTSPLY SIRONA’s payout ratio is -145.45%.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on XRAY shares. Needham & Company LLC restated a “buy” rating and issued a $34.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, August 20th. Stifel Nicolaus decreased their price target on shares of DENTSPLY SIRONA from $30.00 to $28.00 and set a “hold” rating for the company in a report on Thursday, July 18th. Evercore ISI dropped their price objective on DENTSPLY SIRONA from $28.00 to $27.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $33.00 to $31.00 and set a “neutral” rating for the company in a research note on Monday, July 22nd. Finally, Barrington Research reaffirmed an “outperform” rating and issued a $38.00 price target on shares of DENTSPLY SIRONA in a research report on Monday, July 8th. Five analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $33.44.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.